Innophos (IPHS) Downgraded by BidaskClub

Innophos (NASDAQ:IPHS) was downgraded by equities researchers at BidaskClub from a “hold” rating to a “sell” rating in a research report issued on Saturday.

A number of other analysts also recently issued reports on IPHS. Zacks Investment Research downgraded shares of Innophos from a “buy” rating to a “hold” rating in a report on Wednesday, January 3rd. KeyCorp reiterated a “hold” rating on shares of Innophos in a report on Wednesday, November 1st.

Shares of Innophos (IPHS) opened at $47.24 on Friday. The company has a market cap of $900.87, a price-to-earnings ratio of 21.77 and a beta of 0.85. Innophos has a 52-week low of $41.66 and a 52-week high of $58.22. The company has a debt-to-equity ratio of 0.83, a quick ratio of 1.49 and a current ratio of 2.86.

Innophos (NASDAQ:IPHS) last announced its quarterly earnings results on Tuesday, October 31st. The specialty chemicals company reported $0.78 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.72 by $0.06. The company had revenue of $184.00 million for the quarter, compared to the consensus estimate of $179.33 million. Innophos had a net margin of 6.19% and a return on equity of 13.90%. Innophos’s revenue for the quarter was down 1.1% compared to the same quarter last year. During the same period in the previous year, the firm posted $0.69 EPS. analysts anticipate that Innophos will post 2.5 earnings per share for the current fiscal year.

A number of hedge funds and other institutional investors have recently made changes to their positions in the business. The Manufacturers Life Insurance Company increased its holdings in Innophos by 0.9% in the 2nd quarter. The Manufacturers Life Insurance Company now owns 14,962 shares of the specialty chemicals company’s stock valued at $656,000 after acquiring an additional 130 shares during the last quarter. Public Employees Retirement System of Ohio increased its holdings in Innophos by 5.9% in the 2nd quarter. Public Employees Retirement System of Ohio now owns 2,824 shares of the specialty chemicals company’s stock valued at $124,000 after acquiring an additional 157 shares during the last quarter. Voya Investment Management LLC increased its holdings in Innophos by 8.2% in the 2nd quarter. Voya Investment Management LLC now owns 10,214 shares of the specialty chemicals company’s stock valued at $448,000 after acquiring an additional 776 shares during the last quarter. Stevens Capital Management LP increased its holdings in Innophos by 18.0% in the 3rd quarter. Stevens Capital Management LP now owns 7,006 shares of the specialty chemicals company’s stock valued at $345,000 after acquiring an additional 1,070 shares during the last quarter. Finally, Thrivent Financial For Lutherans increased its holdings in Innophos by 5.1% in the 2nd quarter. Thrivent Financial For Lutherans now owns 24,910 shares of the specialty chemicals company’s stock valued at $1,092,000 after acquiring an additional 1,200 shares during the last quarter. Institutional investors own 94.46% of the company’s stock.

COPYRIGHT VIOLATION WARNING: This piece was reported by American Banking News and is owned by of American Banking News. If you are viewing this piece on another publication, it was illegally stolen and republished in violation of U.S. and international copyright & trademark laws. The legal version of this piece can be read at https://www.americanbankingnews.com/2018/01/20/innophos-iphs-downgraded-by-bidaskclub.html.

About Innophos

Innophos Holdings, Inc is a producer of nutritional specialty ingredients with applications in food, beverage, dietary supplements, pharmaceutical, oral care and industrial end markets. The Company also provides bioactive mineral and nutritional ingredients. The Company’s segments include Specialty Phosphates US & Canada, Specialty Phosphates Mexico, and Granular Triple Super Phosphate (GTSP) & Other.

Receive News & Ratings for Innophos Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innophos and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply